Ampicillin Dosing and Duration for Enterococcus faecalis Infections
For Enterococcus faecalis infections, the recommended dose of ampicillin is 2 grams IV every 4 hours for 4-6 weeks, with duration depending on the site of infection and clinical response. 1
Dosing Recommendations by Infection Type
Urinary Tract Infections
- Uncomplicated UTI: 500 mg orally four times daily 2
- Complicated UTI: 500 mg orally four times daily; severe infections may require larger doses 2
- High-dose for ampicillin-resistant VRE in UTI: 18-30 g IV daily in divided doses 1
Endocarditis
- Native valve endocarditis: 2 g IV every 4 hours for 4-6 weeks 1
- 4 weeks if symptoms present <3 months
- 6 weeks if symptoms present >3 months
- Prosthetic valve endocarditis: 2 g IV every 4 hours for at least 6 weeks 1
Combination Therapy Options
- For aminoglycoside-resistant strains: Ampicillin plus ceftriaxone 1, 3
- Ampicillin 2 g IV every 4 hours
- Ceftriaxone 2 g IV every 12 hours
- Duration: 6 weeks regardless of symptom duration
Treatment Algorithm Based on Infection Site and Resistance Pattern
Identify infection site and severity:
- UTI (uncomplicated vs complicated)
- Endocarditis (native vs prosthetic valve)
- Bacteremia
- Other systemic infections
Check susceptibility testing:
- Ampicillin-susceptible: Use ampicillin monotherapy
- Aminoglycoside-resistant: Use ampicillin-ceftriaxone combination
- Vancomycin-resistant: Consider high-dose ampicillin for UTI
Determine appropriate dosing:
Determine appropriate duration:
Special Considerations
Pediatric Dosing
- Children weighing ≤20 kg: 100 mg/kg/day in 4 equally divided doses for GU/GI infections 2
- Children weighing >20 kg: Adult dosing 2
Administration Timing
- Administer at least 30 minutes before or 2 hours after meals for maximal absorption 2
Monitoring
- For endocarditis, monitor for clinical improvement and clearance of bacteremia
- For UTI, clinical appraisal is necessary during therapy and may be needed for several months afterward 2
Potential Pitfalls and Caveats
- Resistance concerns: E. faecalis can develop resistance to ampicillin. Recent studies show ampicillin remains effective against many E. faecalis isolates, but susceptibility testing is crucial 4
- Combination therapy: For serious infections like endocarditis, combination therapy may be necessary, especially with aminoglycoside-resistant strains 1, 3
- Duration of therapy: Insufficient treatment duration is a common pitfall. Ensure adequate duration based on infection site and clinical response 1
- Distinguishing colonization from infection: Particularly important in catheterized patients to avoid unnecessary treatment 5
The ampicillin-ceftriaxone combination has shown excellent efficacy for treating HLAR E. faecalis endocarditis with 100% cure rates in patients completing the protocol 3, making it a valuable option when aminoglycoside combinations cannot be used due to resistance or risk of nephrotoxicity.